Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,042 | -20,342 | -13,080 | -10,293 | -4,596 |
| Depreciation Amortization | 6,436 | 4,470 | 2,190 | 5,902 | 3,679 |
| Accounts receivable | 253 | 898 | 906 | -1,748 | 69 |
| Accounts payable and accrued liabilities | 464 | 718 | 864 | -2,550 | -1,693 |
| Other Working Capital | -1,890 | -104 | 2,201 | -1,119 | -2,398 |
| Other Operating Activity | 35,526 | 13,145 | 6,548 | -7,361 | -8,237 |
| Operating Cash Flow | $-3,253 | $-1,215 | $-371 | $-17,169 | $-13,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156 | -169 | -18 | 332 | 1,022 |
| Investing Cash Flow | $-156 | $-169 | $-18 | $332 | $1,022 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,196 | 2,678 | N/A | 19,807 | 15,946 |
| Debt Repayment | -130 | -85 | -44 | -2,981 | -174 |
| Common Stock Issued | N/A | N/A | N/A | 100 | 100 |
| Other Financing Activity | -710 | -1,167 | -610 | 458 | -3,208 |
| Financing Cash Flow | $3,356 | $1,426 | $-654 | $17,384 | $12,664 |
| Exchange Rate Effect | -5 | -13 | -4 | -13 | -17 |
| Beginning Cash Position | 1,153 | 1,153 | 1,153 | 619 | 619 |
| End Cash Position | 1,095 | 1,182 | 106 | 1,153 | 1,112 |
| Net Cash Flow | $-58 | $29 | $-1,047 | $534 | $493 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,253 | -1,215 | -371 | -17,169 | -13,176 |
| Capital Expenditure | -169 | -169 | -18 | N/A | 0 |
| Free Cash Flow | -3,422 | -1,384 | -389 | -17,169 | -13,176 |